However, ATR inhibition did not result in a therapeutic window between HNSCC and primary cells, as established with Chk1 inhibition, which may relate to the specificity of the inhibitors or a novel role of Chk1 in HNSCC. Here, ATR is linked to head and neck squamous cell carcinoma.